Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Study identifies factors linked to greater myopia progression in children
  • Myopia

Study identifies factors linked to greater myopia progression in children

Kelsey Moroz

Younger children with higher baseline levels of myopia are more likely to experience faster progression of myopia and eye growth, according to a study.

Researchers analyzed data from a 30-month clinical trial of 5- to 12-year-old children with moderate myopia, comparing effects of atropine 0.01% and a placebo. Both treatment groups were pooled due to similar outcomes.

Out of 187 participants, 94% completed the study. Key findings showed that younger age and higher levels of baseline myopia were linked to faster progression. Younger children experienced a mean refractive error change of -0.19 D for each year younger (95% CI, -0.25 to -0.14 D; P < 0.001), while higher initial myopia was also associated with greater progression (-0.14 D per diopter; P = 0.002). Similarly, axial length increased more in younger children (0.13 mm per year; P < 0.001) and those with higher baseline myopia (0.04 mm per diopter; P = 0.04).

Reference
Weise KK, Repka MX, Zhu Y, et al; Pediatric Eye Disease Investigator Group. Baseline factors associated with myopia progression and axial elongation over 30 months in children 5 to 12 years of age. Optom Vis Sci. 2024;101(10):619-626. doi: 10.1097/OPX.0000000000002187. PMID: 39480129.

Share

Related Content

  • Ocular Surface Disease

Childhood-onset allergic eye disease linked to greater ocular morbidity

  • Contact Lenses

DIMS spectacle lenses noninferior to orthokeratology for slowing myopia progression in children

  • Myopia

Long-term DIMS lens users report high satisfaction despite cost barrier

  • Myopia

Low-dose atropine slowed myopia progression in children with advanced myopia in pilot trial

  • Myopia

Red-light therapy outperforms low-dose atropine in altering macular morphology

  • Myopia

Axial length monitoring may help assess myopia control success in clinical practice

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon